Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína

Detalhes bibliográficos
Autor(a) principal: Rangel, Karen Cristina
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFSCAR
Texto Completo: https://repositorio.ufscar.br/handle/ufscar/7507
Resumo: The available drugs for treating Chagas disease are not effective, therefore the development of new therapies is needed. Cruzain is the major Trypanosoma cruzi cysteine protease, the causative agent of the disease, and is a validated therapeutic target for the discovery of new trypanocidal agents. Our group has identified a cruzain inhibitor with fragment characteristics - [5- (2-chlorophenyl) -1,3,4- oxadiazol-2-yl] acetic acid (Neq0147) and its mode of interaction was validated by determining orthogonally its crystal structure. However, interactions of this inhibitor were not yet appropriately optimized. Therefore, this study aimed to optimize the interactions of Neq0147 to identify new fragments as non-peptide cruzain inhibitors, which was carried out through a structure-activity relationship study (SAR). Molecular modifications have been made based on Neq0147, wherein initially carboxylate was replaced by a nitrile to increase the affinity of the inhibitor and to act as an anchor to explore other modifications. Then it was made the replacement of the 1,3,4-oxadiazole ring for others heterocyclic five-membered rings, with the intention to explore interactions with Asp161 and Gly65. The position of the chlorine atom on the aromatic ring was also varied to explore interactions with amino acids in the S2 subsite. The compounds were tested against cruzain to determine its inhibition constant. From the SAR study it can be concluded that the change that generated higher affinity gain was the replacement of the carboxylate group by nitrile. It can also be seen that the presence of chlorine is essential for the fragments activity, which preferably should be present in the ortho or para positions. Among the evaluated inhibitors one fragment, Neq0617, has an affinity 14 times greater than the original fragment. Moreover, various inhibitors similar to fragments with high affinity and interaction efficiency have been identified, therefore these inhibitors are potential candidates for optimization.
id SCAR_55e8d03bf683445aa48e1dec65dd00b8
oai_identifier_str oai:repositorio.ufscar.br:ufscar/7507
network_acronym_str SCAR
network_name_str Repositório Institucional da UFSCAR
repository_id_str 4322
spelling Rangel, Karen CristinaMontanari, Carlos Albertohttp://lattes.cnpq.br/9200533791228786http://lattes.cnpq.br/472638402746243063527a94-ecb2-43ec-9b11-85a5a524fc882016-09-27T19:33:03Z2016-09-27T19:33:03Z2015-08-24RANGEL, Karen Cristina. Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína. 2015. Dissertação (Mestrado em Química) – Universidade Federal de São Carlos, São Carlos, 2015. Disponível em: https://repositorio.ufscar.br/handle/ufscar/7507.https://repositorio.ufscar.br/handle/ufscar/7507The available drugs for treating Chagas disease are not effective, therefore the development of new therapies is needed. Cruzain is the major Trypanosoma cruzi cysteine protease, the causative agent of the disease, and is a validated therapeutic target for the discovery of new trypanocidal agents. Our group has identified a cruzain inhibitor with fragment characteristics - [5- (2-chlorophenyl) -1,3,4- oxadiazol-2-yl] acetic acid (Neq0147) and its mode of interaction was validated by determining orthogonally its crystal structure. However, interactions of this inhibitor were not yet appropriately optimized. Therefore, this study aimed to optimize the interactions of Neq0147 to identify new fragments as non-peptide cruzain inhibitors, which was carried out through a structure-activity relationship study (SAR). Molecular modifications have been made based on Neq0147, wherein initially carboxylate was replaced by a nitrile to increase the affinity of the inhibitor and to act as an anchor to explore other modifications. Then it was made the replacement of the 1,3,4-oxadiazole ring for others heterocyclic five-membered rings, with the intention to explore interactions with Asp161 and Gly65. The position of the chlorine atom on the aromatic ring was also varied to explore interactions with amino acids in the S2 subsite. The compounds were tested against cruzain to determine its inhibition constant. From the SAR study it can be concluded that the change that generated higher affinity gain was the replacement of the carboxylate group by nitrile. It can also be seen that the presence of chlorine is essential for the fragments activity, which preferably should be present in the ortho or para positions. Among the evaluated inhibitors one fragment, Neq0617, has an affinity 14 times greater than the original fragment. Moreover, various inhibitors similar to fragments with high affinity and interaction efficiency have been identified, therefore these inhibitors are potential candidates for optimization.Os fármacos disponíveis para o tratamento da doença de Chagas não são eficazes, portanto é necessário o desenvolvimento de novas alternativas terapêuticas. A cruzaína é a principal cisteínoprotease do Trypanosoma cruzi, agente causador da doença, e é um alvo terapêutico validado para a descoberta de novos agentes tripanossomicidas. Nosso grupo identificou um inibidor de cruzaína com características de fragmento, o ácido [5- (2- clorofenil) -1,3,4-oxadiazol-2-il] acético (Neq0147), e seu modo de ligação foi validado ortogonalmente através da determinação de sua estrutura cristalográfica. No entanto, as interações deste inibidor ainda não estavam otimizadas de maneira adequada. Então este trabalho teve como objetivo a otimização das interações do Neq0147 para identificação de novos fragmentos como inibidores não peptidícos da cruzaína, que foi realizado através de um estudo de relação estrutura-atividade (SAR). Modificações moleculares foram feitas baseadas no Neq0147, sendo que inicialmente o carboxilato foi substituído por uma nitrila para aumentar a afinidade do inibidor e atuar como âncora para explorar outras modificações. Em seguida, foi feita a substituição do anel 1,3,4- oxadiazol por outros anéis heterocíclicos de cinco membros, com a intenção de explorar interações com o Asp161 e a Gly65. A posição do átomo de cloro no anel aromático também foi variada para explorar interações com aminoácidos presentes no subsítio S2. Os compostos foram testados contra a cruzaína para a determinação da sua constante de inibição (Ki). A partir do estudo de SAR, pode-se concluir que a modificação que gerou maior ganho de afinidade foi à substituição do grupo carboxilato pela nitrila. Também pode-se observar que a presença do átomo de cloro é essencial para a atividade dos fragmentos, sendo que preferencialmente deve estar presente nas posições orto ou para. Entre os inibidores avaliados um fragmento, Neq0617, teve uma afinidade 14 vezes maior do que a do fragmento inicial. Além disso, vários inibidores similares a fragmentos com alta afinidade e eficiência de interação foram identificados, portanto estes inibidores são potencias candidatos para otimização.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)porUniversidade Federal de São CarlosCâmpus São CarlosPrograma de Pós-Graduação em Química - PPGQUFSCarQuímica orgânicaQuímica medicinalChagas, Doença deCruzaínaFragmentosInibidoresCIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ORGANICA::FISICO-QUIMICA ORGANICAPlanejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaínaMolecular design and evaluation of molecular fragments-like cruzain inhibitorsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisOnline60060099488e9a-d28d-4248-a854-9d36d6a2a25binfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSCARinstname:Universidade Federal de São Carlos (UFSCAR)instacron:UFSCARORIGINALDissKCR.pdfDissKCR.pdfapplication/pdf5575397https://repositorio.ufscar.br/bitstream/ufscar/7507/1/DissKCR.pdf00bd8d0d865352126acd47e7512ab06eMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81957https://repositorio.ufscar.br/bitstream/ufscar/7507/2/license.txtae0398b6f8b235e40ad82cba6c50031dMD52TEXTDissKCR.pdf.txtDissKCR.pdf.txtExtracted texttext/plain139911https://repositorio.ufscar.br/bitstream/ufscar/7507/3/DissKCR.pdf.txtd60705e449964217d2dff2c8f78aff6bMD53THUMBNAILDissKCR.pdf.jpgDissKCR.pdf.jpgIM Thumbnailimage/jpeg9089https://repositorio.ufscar.br/bitstream/ufscar/7507/4/DissKCR.pdf.jpg9c52d3c83edbe0de8fe866f13f2bed86MD54ufscar/75072023-09-18 18:30:55.674oai:repositorio.ufscar.br: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Repositório InstitucionalPUBhttps://repositorio.ufscar.br/oai/requestopendoar:43222023-09-18T18:30:55Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)false
dc.title.por.fl_str_mv Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
dc.title.alternative.eng.fl_str_mv Molecular design and evaluation of molecular fragments-like cruzain inhibitors
title Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
spellingShingle Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
Rangel, Karen Cristina
Química orgânica
Química medicinal
Chagas, Doença de
Cruzaína
Fragmentos
Inibidores
CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ORGANICA::FISICO-QUIMICA ORGANICA
title_short Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
title_full Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
title_fullStr Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
title_full_unstemmed Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
title_sort Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína
author Rangel, Karen Cristina
author_facet Rangel, Karen Cristina
author_role author
dc.contributor.authorlattes.por.fl_str_mv http://lattes.cnpq.br/4726384027462430
dc.contributor.author.fl_str_mv Rangel, Karen Cristina
dc.contributor.advisor1.fl_str_mv Montanari, Carlos Alberto
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/9200533791228786
dc.contributor.authorID.fl_str_mv 63527a94-ecb2-43ec-9b11-85a5a524fc88
contributor_str_mv Montanari, Carlos Alberto
dc.subject.por.fl_str_mv Química orgânica
Química medicinal
Chagas, Doença de
Cruzaína
Fragmentos
Inibidores
topic Química orgânica
Química medicinal
Chagas, Doença de
Cruzaína
Fragmentos
Inibidores
CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ORGANICA::FISICO-QUIMICA ORGANICA
dc.subject.cnpq.fl_str_mv CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ORGANICA::FISICO-QUIMICA ORGANICA
description The available drugs for treating Chagas disease are not effective, therefore the development of new therapies is needed. Cruzain is the major Trypanosoma cruzi cysteine protease, the causative agent of the disease, and is a validated therapeutic target for the discovery of new trypanocidal agents. Our group has identified a cruzain inhibitor with fragment characteristics - [5- (2-chlorophenyl) -1,3,4- oxadiazol-2-yl] acetic acid (Neq0147) and its mode of interaction was validated by determining orthogonally its crystal structure. However, interactions of this inhibitor were not yet appropriately optimized. Therefore, this study aimed to optimize the interactions of Neq0147 to identify new fragments as non-peptide cruzain inhibitors, which was carried out through a structure-activity relationship study (SAR). Molecular modifications have been made based on Neq0147, wherein initially carboxylate was replaced by a nitrile to increase the affinity of the inhibitor and to act as an anchor to explore other modifications. Then it was made the replacement of the 1,3,4-oxadiazole ring for others heterocyclic five-membered rings, with the intention to explore interactions with Asp161 and Gly65. The position of the chlorine atom on the aromatic ring was also varied to explore interactions with amino acids in the S2 subsite. The compounds were tested against cruzain to determine its inhibition constant. From the SAR study it can be concluded that the change that generated higher affinity gain was the replacement of the carboxylate group by nitrile. It can also be seen that the presence of chlorine is essential for the fragments activity, which preferably should be present in the ortho or para positions. Among the evaluated inhibitors one fragment, Neq0617, has an affinity 14 times greater than the original fragment. Moreover, various inhibitors similar to fragments with high affinity and interaction efficiency have been identified, therefore these inhibitors are potential candidates for optimization.
publishDate 2015
dc.date.issued.fl_str_mv 2015-08-24
dc.date.accessioned.fl_str_mv 2016-09-27T19:33:03Z
dc.date.available.fl_str_mv 2016-09-27T19:33:03Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv RANGEL, Karen Cristina. Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína. 2015. Dissertação (Mestrado em Química) – Universidade Federal de São Carlos, São Carlos, 2015. Disponível em: https://repositorio.ufscar.br/handle/ufscar/7507.
dc.identifier.uri.fl_str_mv https://repositorio.ufscar.br/handle/ufscar/7507
identifier_str_mv RANGEL, Karen Cristina. Planejamento e avaliação de fragmentos moleculares como inibidores da enzima cruzaína. 2015. Dissertação (Mestrado em Química) – Universidade Federal de São Carlos, São Carlos, 2015. Disponível em: https://repositorio.ufscar.br/handle/ufscar/7507.
url https://repositorio.ufscar.br/handle/ufscar/7507
dc.language.iso.fl_str_mv por
language por
dc.relation.confidence.fl_str_mv 600
600
dc.relation.authority.fl_str_mv 99488e9a-d28d-4248-a854-9d36d6a2a25b
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Química - PPGQ
dc.publisher.initials.fl_str_mv UFSCar
publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFSCAR
instname:Universidade Federal de São Carlos (UFSCAR)
instacron:UFSCAR
instname_str Universidade Federal de São Carlos (UFSCAR)
instacron_str UFSCAR
institution UFSCAR
reponame_str Repositório Institucional da UFSCAR
collection Repositório Institucional da UFSCAR
bitstream.url.fl_str_mv https://repositorio.ufscar.br/bitstream/ufscar/7507/1/DissKCR.pdf
https://repositorio.ufscar.br/bitstream/ufscar/7507/2/license.txt
https://repositorio.ufscar.br/bitstream/ufscar/7507/3/DissKCR.pdf.txt
https://repositorio.ufscar.br/bitstream/ufscar/7507/4/DissKCR.pdf.jpg
bitstream.checksum.fl_str_mv 00bd8d0d865352126acd47e7512ab06e
ae0398b6f8b235e40ad82cba6c50031d
d60705e449964217d2dff2c8f78aff6b
9c52d3c83edbe0de8fe866f13f2bed86
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)
repository.mail.fl_str_mv
_version_ 1802136306895028224